Position in NKTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,051,131
+$170,899 QoQ
Shares Held
371,425
-11.0% QoQ
Ownership
0.519%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 136 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in NKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,568,275 across 424 Biotechnology names. NKTX ranks #274 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in NKTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,051,131 | 371,425 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $880,232 | 417,172 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $665,307 | 359,626 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $780,214 | 376,916 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $767,199 | 462,169 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $868,153 | 471,823 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,168,207 | 469,160 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $2,107,689 | 466,303 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,029,032 | 343,322 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,429,223 | 317,227 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,116,942 | 320,749 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $448,457 | 322,632 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $694,043 | 316,915 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $970,679 | 273,431 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,800,510 | 300,586 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,686,720 | 280,146 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,440,076 | 279,227 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,604,316 | 140,977 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,286,903 | 148,984 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $4,063,068 | 146,101 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,055,473 | 159,529 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $7,291,955 | 221,640 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $13,042,640 | 212,179 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $6,190,736 | 205,946 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||